LOCATELLI, VITTORIO
 Distribuzione geografica
Continente #
NA - Nord America 10.444
EU - Europa 4.582
AS - Asia 2.052
SA - Sud America 71
AF - Africa 13
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 9
Totale 17.183
Nazione #
US - Stati Uniti d'America 10.257
IT - Italia 961
SG - Singapore 787
DE - Germania 733
CN - Cina 639
RU - Federazione Russa 563
IE - Irlanda 515
SE - Svezia 514
UA - Ucraina 470
HK - Hong Kong 335
GB - Regno Unito 276
CA - Canada 184
FI - Finlandia 139
AT - Austria 110
FR - Francia 74
ID - Indonesia 68
IN - India 66
BR - Brasile 65
DK - Danimarca 54
TR - Turchia 53
NL - Olanda 44
BE - Belgio 42
VN - Vietnam 42
BG - Bulgaria 21
PL - Polonia 17
JP - Giappone 16
CH - Svizzera 15
KR - Corea 12
EU - Europa 11
IR - Iran 9
CZ - Repubblica Ceca 8
AU - Australia 6
RO - Romania 6
EE - Estonia 5
EG - Egitto 5
ES - Italia 5
TW - Taiwan 5
SC - Seychelles 4
AR - Argentina 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
PT - Portogallo 3
AE - Emirati Arabi Uniti 2
CL - Cile 2
HU - Ungheria 2
IL - Israele 2
KG - Kirghizistan 2
MX - Messico 2
MY - Malesia 2
TH - Thailandia 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CO - Colombia 1
CR - Costa Rica 1
HR - Croazia 1
IQ - Iraq 1
JO - Giordania 1
KZ - Kazakistan 1
LI - Liechtenstein 1
LT - Lituania 1
MA - Marocco 1
MD - Moldavia 1
MU - Mauritius 1
PH - Filippine 1
SI - Slovenia 1
TJ - Tagikistan 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 17.183
Città #
Ann Arbor 1.605
Woodbridge 1.090
Fairfield 979
Houston 784
Chandler 735
Wilmington 716
Ashburn 550
Singapore 546
Frankfurt am Main 531
Jacksonville 504
Dublin 494
Seattle 441
Hong Kong 334
Dearborn 323
Cambridge 310
Milan 263
New York 216
Princeton 211
Santa Clara 172
Nanjing 135
Vienna 103
Lawrence 87
Altamura 86
Lachine 82
Shanghai 78
Beijing 69
Jakarta 67
Boardman 57
Helsinki 53
Council Bluffs 51
Detroit 44
Guangzhou 43
Brussels 41
Nanchang 41
Falls Church 40
Moscow 40
San Diego 40
London 39
Rome 37
Hebei 32
Andover 28
Mountain View 26
Shenyang 26
Huizen 24
Toronto 24
Changsha 23
Elora 23
Fremont 22
Nuremberg 22
Chicago 21
Grafing 20
Jiaxing 20
Tianjin 20
Ottawa 19
Los Angeles 18
Philadelphia 18
Renton 18
Hangzhou 17
Kunming 17
Pune 17
Plovdiv 16
Jinan 14
Turin 14
Norwalk 13
Monza 12
Ningbo 12
Romola 12
Munich 11
Auburn Hills 10
Bologna 10
Dong Ket 10
Sacramento 10
Carate Brianza 9
Lissone 9
Edmonton 8
Pavia 8
Russi 8
Taizhou 8
Thunder Bay 8
Tokyo 8
University Park 8
Bari 7
Dallas 7
Kiev 7
Kocaeli 7
São Paulo 7
Zhengzhou 7
Chiavari 6
Leawood 6
Modena 6
Pisa 6
Rho 6
San Mateo 6
Southend 6
Tappahannock 6
Virginia Beach 6
Zurich 6
Arcore 5
Bergamo 5
Bodio Lomnago 5
Totale 12.827
Nome #
Anti-inflammatory effects of palmitoylethanolamide in activated microglial cells 357
Growth hormone secretagogues and the regulation of calcium signaling in muscle 335
Intra-Articular Cytokine Levels in Adolescent Patients after Anterior Cruciate Ligament Tear 290
TLQP-21, A VGF-derived peptide endowed of endocrine and extraendocrine properties: Focus on in vitro calcium signaling 287
STIM Proteins and Orai Ca2+ Channels Are Involved in the Intracellular Pathways Activated by TLQP-21 in RAW264.7 Macrophages 261
JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia 239
Role of interleukin-10 in the synovial fluid of the anterior cruciate ligament injured knee 239
Effects of ACL Reconstructive Surgery on Temporal Variations of Cytokine Levels in Synovial Fluid 231
Hexarelin modulation of mapk and pi3k/akt pathways in neuro-2a cells inhibits hydrogen peroxide-induced apoptotic toxicity 229
Novel domain-selective ACE-inhibiting activity of synthetic growth hormone secretagogues 222
Biophysical characterization of a binding site for TLQP-21, a naturally occurring peptide which induces resistance to obesity 221
JMV5656, a novel derivative of TLQP-21, triggers the activation of a calcium-dependent potassium outward current in microglial cells 216
Ontogeny and tissue-specific regulation of ghrelin mRNA expression suggest that ghrelin is primarily involved in the control of extraendocrine functions in the rat 214
Neurotrophic and neuroregenerative effects of GH/IGF1 213
Characterization of synovial fluid cytokine profiles in chronic meniscal tear of the knee 208
Hexarelin modulates the expression of growth hormone secretagogue receptor type 1a mRNA at hypothalamic and pituitary sites 199
Pharmacological and Biochemical Characterization of TLQP-21 Activation of a Binding Site on CHO Cells 197
Characterization of a novel peripheral pro-lipolytic mechanism in mice: role of VGF-derived peptide TLQP-21 196
Acute and late changes in intraarticular cytokine levels following anterior cruciate ligament injury 195
Ghrelin plays a minor role in the physiological control of cardiac function in the rat 194
Feeding behavior during long-term hexarelin administration in young and old rats 194
miRNA-218 targets lipin-1 and glucose transporter type 4 genes in 3T3-L1 cells treated with lopinavir/ritonavir 192
Somatotropic dysregulation in old mammals 188
Mechanism of action of Hexarelin. I. Growth hormone-releasing activity in the rat 187
Ghrelin in gastroenteric pathophysiology 186
TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity 180
Studio longitudinale sul benessere e le attitudini degli Studenti di Medicina e Chirurgia. Primi risultati della fase 1 - Le caratteristiche degli studenti selezionati. 178
Characterisation of gastric ghrelin cells in man and other mammals: studies in adult and fetal tissues 177
Novel hexarelin analogs stimulate feeding in the rat through a mechanism not involving growth hormone release 177
Age-dependent modulation by galanin of growth hormone release from rat pituitary cells in culture 173
Evidence for a central inhibitory role of growth hormone secretagogues and ghrelin on gastric acid secretion in conscious rats 173
Chronic intracerebroventricular injection of TLQP-21 prevents high fat diet induced weight gain in fast weight-gaining mice 172
Cholinergic agonist and antagonist drugs modulate the growth hormone response to growth hormone-releasing hormone in the rat: evidence for mediation by somatostatin 172
Effects of hexarelin against acid-independent and acid-dependent ulcerogens in the rat 171
Obestatin inhibits feeding but does not modulate GH and corticosterone secretion in the rat 171
Central dysregulations in the control of energy homeostasis and endocrine alterations in anorexia and bulimia nervosa 171
Central ghrelin gastroprotection involves nitric oxide/prostaglandin cross-talk 171
Changes in subcutaneous adipose tissue microRNA expression in HIV-infected patients 170
Central nervous system-acting drugs influencing hypothalamic-pituitary-adrenal axis function 170
Beneficial effects of desacyl-ghrelin, hexarelin and EP-80317 in models of status epilepticus 169
Ghrelin control of GH secretion and feeding behaviour: The role of the GHS-R1a receptor studied in vivo and in vitro using novel non-peptide ligands 167
Penile erection induced by EP 80661 and other hexarelin peptide analogues: Involvement of paraventricular nitric oxide 164
Ghrelin expression and actions: A novel peptide for an old cell type of the diffuse endocrine system 163
Involvement of the somatostatin and cholinergic systems in the mechanism of growth hormone autofeedback regulation in the rat 163
Effects of GH and IGF-I administration on GHRH and somatostatin mRNA levels: I. A study on ad libitum fed and starved adult male rats 163
Intracerebroventricular acute and chronic administration of obestatin minimally affect food intake but not weight gain in the rat. 161
Growth hormone and hexarelin prevent endothelial vasodilator dysfunction in aortic rings of the hypophysectomized rat 161
Growth hormone-releasing hexapeptide is a potent stimulator of growth hormone gene expression and release in the growth hormone-releasing hormone-deprived infant rat 160
GH-releasing activity of Hexarelin, a new growth hormone releasing peptide, in infant and adult rats 158
Desacyl-ghrelin and Synthetic GH-secretagogues Modulate the Production of Inflammatory Cytokines in Mouse Microglia Cells Stimulated by beta-Amyloid Fibrils 157
Functional and Structural Characterization of a Binding Site for TLQP-21, a VGF-Derived Peptide 157
Growth hormone-inhibiting activity of cortistatin in the rat 156
New trisubstituted 1,2,4-triazole derivatives as potent ghrelin receptor antagonists. 3. Synthesis and pharmacological in vitro and in vivo evaluations 155
Long-term changes of somatotrophic function induced by deprivation of growth hormone-releasing hormone during the fetal life of the rat 155
Growth hormone secretagogues: focus on the growth hormone-releasing peptides 155
Effect of GH/IGF-1 on Bone Metabolism and Osteoporsosis 155
EP 60761 and EP 50885, two hexarelin analogues, induce penile erection in rats 154
Short ghrelin peptides neither displace ghrelin binding in vitro nor stimulate GH release in vivo 153
Somatotropic dysfunction in growth hormone-releasing hormone-deprived neonatal rats: effect of growth hormone replacement therapy 152
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis 151
Growth hormone-independent cardioprotective effects of hexarelin in the rat 149
Ghrelin inhibits inflammatory pain in rats: Involvement of the opioid system 147
Utilizzo dei growth hormone secretagogues per bloccare o inibire l'attività del sistema renina-angiotensina 147
Protective but not anticonvulsant effects of ghrelin and JMV-1843 in the pilocarpine model of Status epilepticus 147
Pyruvate and satiety: can we fool the brain? 146
Hexarelin modulates lung mechanics, inflammation, and fibrosis in acute lung injury 146
Moexipril and quinapril inhibition of tissue angiotensin-converting enzyme activity in the rat: Evidence for direct effects in heart, lung and kidney and stimulation of prostacyclin generation 145
IGF-I stimulates proliferation of spontaneously immortalized human keratinocytes (HACAT) by autocrine/paracrine mechanisms 143
La valutazione delle attività di tirocinio pratico da parte dei tutori 143
Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Pathophysiological, diagnostic and therapeutic implications 142
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis 142
The somatostatin subtype-2 receptor antagonist, BIM-23627, improves the catabolic effects induced by long-term glucocorticoid treatment in the rat. 141
Age-related modulatory activity by a cholinergic agonist on the growth hormone response to GH-releasing hormone in the rat 141
Hexarelin stimulation of growth hormone release and mrna levels in an infant and adult rat model of impaired ghrh function 141
PHARMACOLOGICAL CHARACTERIZATION OF A BINDING SITE FOR TLQP-21, A VGF-DERIVED PEPTIDE 140
Testosterone a key factor in gender related metabolic syndrome 140
Neural stem cells release soluble factors that modulate inflammatory cytokines expression in microglia 139
Low dose of insulin for assessment of growth hormone and cortisol release in short children 138
Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein 136
Chronic intracerebroventricular TLQP-21 delivery does not modulate the GH/IGF-1-axis and muscle strength in mice 136
EP 60761- and EP 50885-induced penile erection: structure-activity studies and comparison with apomorphine, oxytocin and N-methyl-D-aspartic acid 136
Effects of GH and IGF-I administration on GHRH and somatostatin mRNA levels: II. A study in the infant rat 135
Differential orexigenic effects of hexarelin and its analogs in the rat hypothalamus: indication for multiple growth hormone secretagogue receptor subtypes 133
La somatopausa: nuove prospettive terapeutiche 130
Toward potent ghrelin receptor ligands based on trisubstituted 1,2,4-triazole structure. 2. Synthesis and pharmacological in vitro and in vivo evaluations 128
L’accesso a Medicina. Best evidence-based practice, requisito indispensabile per una ipotesi di “Processo di Selezione” centrato sulla realtà formativa italiana e di caratura internazionale 126
Key Learning Outcomes for Clinical Pharmacology and Therapeutics Education in Europe: A Modified Delphi Study 121
Synthesis and pharmacological in vitro and in vivo evaluations of novel triazole derivatives as ligands of the ghrelin receptor. 1 120
Ghrelin expression in gut endocrine growths 119
Characterization of microRNA Levels in Synovial Fluid from Knee Osteoarthritis and Anterior Cruciate Ligament Tears 116
New active series of growth hormone secretagogues 114
EP1572: A novel peptido-mimetic GH secretagogue with potent and selective GH-releasing activity in man 112
Evidence for a role of the GHS-R1a receptors in ghrelin inhibition of gastric acid secretion in the rat 109
Ghrelin protects against ethanol-induced gastric ulcers in rats: studies on the mechanisms of action 109
Ghrelin anticonvulsive properties: is it a matter of desacylation? 108
Chronic i.c.v infusion either of a melanocortin agonist or of an antagonist at low doses profoundly modifies energy balance without any other behavioral effects, in rats 107
Antioxidant and neuroprotective effects of Hexarelin in Neuro-2A cells 104
Uso di agonisti e antagonisti dei recettori per i growth hormone secretagogues per la prevenzione e il trattamento di convulsioni ed epilessia 103
Studio osservazionale comparativo su un campione di studenti del Nord, del Centro e del Sud con valutazione della Maturità, del Test di accesso e delle scelte di sede effettuate al concorso con graduatoria nazionale 2013-2014. Osservazioni preliminari. 103
Inibition of H2O2-induced neurotoxicity in mouse neuroblastoma Neuro2A cells by microvescicles released from hexarelin-stimulated microglial cells 101
Totale 16.628
Categoria #
all - tutte 61.804
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.804


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020406 0 0 0 0 0 0 0 0 0 147 198 61
2020/20211.872 122 112 197 228 149 160 173 150 153 214 83 131
2021/20221.199 63 109 149 57 52 113 57 51 83 109 118 238
2022/20232.766 284 742 282 282 239 421 30 143 181 17 90 55
2023/20241.584 63 73 78 83 225 395 313 44 105 18 28 159
2024/20252.577 215 352 234 239 349 161 271 223 257 276 0 0
Totale 17.616